427 related articles for article (PubMed ID: 15604289)
61. A further characterization of B-CLL lymphocytes: phenotypic and functional studies.
Merle-Béral H
Nouv Rev Fr Hematol (1978); 1990; 32(5):319-21. PubMed ID: 2099403
[TBL] [Abstract][Full Text] [Related]
62. Distinct gene expression in human Vdelta1 and Vdelta2 gammadelta T cells following non-TCR agonist stimulation.
Kress E; Hedges JF; Jutila MA
Mol Immunol; 2006 May; 43(12):2002-11. PubMed ID: 16423401
[TBL] [Abstract][Full Text] [Related]
63. Effect of IL-2R beta-binding cytokines on costimulatory properties of chronic lymphocytic leukaemia cells: implications for immunotherapy.
Spaner DE; Hammond C; Mena J; Shi Y
Br J Haematol; 2004 Dec; 127(5):531-42. PubMed ID: 15566356
[TBL] [Abstract][Full Text] [Related]
64. Human Vδ1 γδ T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells.
Siegers GM; Dhamko H; Wang XH; Mathieson AM; Kosaka Y; Felizardo TC; Medin JA; Tohda S; Schueler J; Fisch P; Keating A
Cytotherapy; 2011 Jul; 13(6):753-64. PubMed ID: 21314241
[TBL] [Abstract][Full Text] [Related]
65. Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes.
Takahashi S; Rousseau RF; Yotnda P; Mei Z; Dotti G; Rill D; Hurwitz R; Marini F; Andreeff M; Brenner MK
Hum Gene Ther; 2001 Apr; 12(6):659-70. PubMed ID: 11426465
[TBL] [Abstract][Full Text] [Related]
66. Persistent ex vivo low number and functional in vitro recovery of circulating gammadelta T cells after removal of a cutaneous primary melanoma.
Provinciali M; Re F; Tucci MG; Ricotti F; Lattanzio F
Scand J Immunol; 2010 Aug; 72(2):142-9. PubMed ID: 20618773
[TBL] [Abstract][Full Text] [Related]
67. Hypogammaglobulinaemia associated with abnormalities of both B and T lymphocytes in patients with chronic lymphatic leukaemia.
Hersey P; Wotherspoon J; Reid G; Gunz FW
Clin Exp Immunol; 1980 Mar; 39(3):698-707. PubMed ID: 6445798
[TBL] [Abstract][Full Text] [Related]
68. Transendothelial migration of lymphocytes in chronic lymphocytic leukaemia is impaired and involved down-regulation of both L-selectin and CD23.
Chen JR; Gu BJ; Dao LP; Bradley CJ; Mulligan SP; Wiley JS
Br J Haematol; 1999 Apr; 105(1):181-9. PubMed ID: 10233382
[TBL] [Abstract][Full Text] [Related]
69. Dendritic cells loaded with apoptotic tumour cells induce a stronger T-cell response than dendritic cell-tumour hybrids in B-CLL.
Kokhaei P; Rezvany MR; Virving L; Choudhury A; Rabbani H; Osterborg A; Mellstedt H
Leukemia; 2003 May; 17(5):894-9. PubMed ID: 12750703
[TBL] [Abstract][Full Text] [Related]
70. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia.
Han T; Ozer H; Minowada J
Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920
[TBL] [Abstract][Full Text] [Related]
71. Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukemia.
Motta M; Rassenti L; Shelvin BJ; Lerner S; Kipps TJ; Keating MJ; Wierda WG
Leukemia; 2005 Oct; 19(10):1788-93. PubMed ID: 16094420
[TBL] [Abstract][Full Text] [Related]
72. Reactivity of B leukemic lymphocytes of patients with chronic lymphocytic leukemia to PWM and PHA.
Isaković K; Lenert G
Blood Cells; 1987; 12(2):355-64. PubMed ID: 3497681
[TBL] [Abstract][Full Text] [Related]
73. Interaction between gamma delta T cells and B cells regulating IgG production.
Häcker G; Adam S; Wagner H
Immunology; 1995 Jan; 84(1):105-10. PubMed ID: 7890294
[TBL] [Abstract][Full Text] [Related]
74. Delta One T Cells for Immunotherapy of Chronic Lymphocytic Leukemia: Clinical-Grade Expansion/Differentiation and Preclinical Proof of Concept.
Almeida AR; Correia DV; Fernandes-Platzgummer A; da Silva CL; da Silva MG; Anjos DR; Silva-Santos B
Clin Cancer Res; 2016 Dec; 22(23):5795-5804. PubMed ID: 27307596
[TBL] [Abstract][Full Text] [Related]
75. Effects of tumour necrosis factor and alpha interferon on chronic B cell malignancies.
Bianchi AC; Heslop HE; Drexler HG; Cordingley FT; Turner M; De Mel WC; Hoffbrand AV; Brenner MK
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):317-9. PubMed ID: 3265501
[TBL] [Abstract][Full Text] [Related]
76. Effects of alpha-interferon and steroids on CD23 expression and release in B-cell chronic lymphocytic leukemia.
Pozzato G; de Paoli P; Franzin F; Tulissi P; Moretti M; Basaglia G; Santini GF
Haematologica; 1994; 79(3):205-12. PubMed ID: 7926968
[TBL] [Abstract][Full Text] [Related]
77. CD23 and chronic lymphocytic leukemia.
Sarfati M
Blood Cells; 1993; 19(3):591-6; discussion 597-9. PubMed ID: 8018941
[TBL] [Abstract][Full Text] [Related]
78. Autologous cytomegalovirus-specific T cells as effector cells in immunotherapy of B cell chronic lymphocytic leukaemia.
Kater AP; Remmerswaal EB; Nolte MA; Eldering E; van Oers MH; van Lier RA
Br J Haematol; 2004 Aug; 126(4):512-6. PubMed ID: 15287944
[TBL] [Abstract][Full Text] [Related]
79. Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate.
Poggi A; Catellani S; Garuti A; Pierri I; Gobbi M; Zocchi MR
Leukemia; 2009 Apr; 23(4):641-8. PubMed ID: 19151770
[TBL] [Abstract][Full Text] [Related]
80. Antiviral activity and anergy of gammadeltaT lymphocytes in cord blood and immuno-compromised host.
Montesano C; Gioia C; Martini F; Agrati C; Cairo C; Pucillo LP; Colizzi V; Poccia F
J Biol Regul Homeost Agents; 2001; 15(3):257-64. PubMed ID: 11693434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
